G0429 – Dermal filler injection(s) for the treatment of facial lipodystrophy syndrome (lds) (e.g., as a result of highly active antiretroviral therapy)

Long description

Dermal filler injection(s) for the treatment of facial lipodystrophy syndrome (lds) (e.g., as a result of highly active antiretroviral therapy)

Short description

Dermal filler injection(s)

Pricing indicator

13 Priced by the Medicare contractor (carrier)

Medicare coverage

C Carrier judgment – coverage decided by the Medicare contractor

BETOS category

P6A Minor procedures - skin

ASC

Approved for ambulatory surgical centers

Added

March 23, 2010

Last change

January 1, 2017 – No change

Nearby G codes

• G0421 – Face-to-face educational services related to the care of chronic kidney disease; group, per session, per one hour
• G0422 – Intensive cardiac rehabilitation; with or without continuous ecg monitoring with exercise, per session
• G0423 – Intensive cardiac rehabilitation; with or without continuous ecg monitoring; without exercise, per session
• G0424 – Pulmonary rehabilitation, including exercise (includes monitoring), one hour, per session, up to two sessions per day
• G0425 – Telehealth consultation, emergency department or initial inpatient, typically 30 minutes communicating with the patient via telehealth
• G0426 – Telehealth consultation, emergency department or initial inpatient, typically 50 minutes communicating with the patient via telehealth
• G0427 – Telehealth consultation, emergency department or initial inpatient, typically 70 minutes or more communicating with the patient via telehealth
• G0428 – Collagen meniscus implant procedure for filling meniscal defects (e.g., cmi, collagen scaffold, menaflex)
• G0431 – Drug screen, qualitative; multiple drug classes by high complexity test method (e.g., immunoassay, enzyme assay), per patient encounter
• G0432 – Infectious agent antibody detection by enzyme immunoassay (eia) technique, hiv-1 and/or hiv-2, screening
• G0433 – Infectious agent antibody detection by enzyme-linked immunosorbent assay (elisa) technique, hiv-1 and/or hiv-2, screening
• G0434 – Drug screen, other than chromatographic; any number of drug classes, by clia waived test or moderate complexity test, per patient encounter
• G0435 – Infectious agent antibody detection by rapid antibody test, hiv-1 and/or hiv-2, screening
• G0436 – Smoking and tobacco cessation counseling visit for the asymptomatic patient; intermediate, greater than 3 minutes, up to 10 minutes
• G0437 – Smoking and tobacco cessation counseling visit for the asymptomatic patient; intensive, greater than 10 minutes
• G0438 – Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit